Envista Holdings (NVST) Exchange Rate Effect (2019 - 2026)
Envista Holdings (NVST) posted quarterly Exchange Rate Effect of -$11.1 million for Q2 2026, down 132.36% year-over-year from $34.3 million in Q2 2025, and down 205.71% quarter-over-quarter from $10.5 million in Q4 2025.
Envista Holdings (NVST) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Envista Holdings' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$11.1 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 132.36% year-over-year to -$11.1 million; the TTM figure through Apr 2026 stood at $43.5 million (up 1075.68% YoY), while the FY2025 annual figure was $88.9 million, up 281.06% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at -$11.1 million, down from $10.5 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $48.1 million in Q2 2025, with the low at -$46.3 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$2.5 million (2022), against an average of $1.5 million.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect tumbled 1323.08% in 2024, then jumped 23950.0% in 2025.
- Envista Holdings' Exchange Rate Effect stood at -$2.5 million in 2022, then surged by 1024.0% to $23.1 million in 2023, then slumped by 300.43% to -$46.3 million in 2024, then soared by 122.68% to $10.5 million in 2025, then plunged by 205.71% to -$11.1 million in 2026.
- Business Quant data shows NVST's Exchange Rate Effect at -$11.1 million in Q2 2026, $10.5 million in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.89 Bn | 129.68 Bn | 1.96 Bn | 7.10 Mn |
| 2 | Becton Dickinson | 52.60 Bn | 51.73 Bn | 2.32 Bn | 2.00 Mn |
| 3 | Alcon | 35.78 Bn | 34.42 Bn | 1.68 Bn | -1.00 Mn |
| 4 | Resmed | 33.93 Bn | 32.46 Bn | 861.22 Mn | 905,000.00 |
| 5 | Medline | 29.16 Bn | 26.49 Bn | 2.22 Bn | -4.00 Mn |
| 6 | West Pharmaceutical Services | 24.87 Bn | 24.43 Bn | 329.20 Mn | -1.60 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 3.00 Mn |
| 8 | Cooper Companies | 14.85 Bn | 14.72 Bn | 735.40 Mn | -3.00 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | - |
| 10 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | -1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -1.40 Mn |
| Jul 3, 2026 | -1.40 Mn |
| Apr 3, 2026 | -11.10 Mn |
| Apr 3, 2026 | -11.10 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Sep 26, 2025 | -4.00 Mn |
| Sep 26, 2025 | -4.00 Mn |
| Jun 27, 2025 | 48.10 Mn |
| Jun 27, 2025 | 48.10 Mn |
| Mar 28, 2025 | 34.30 Mn |
| Mar 28, 2025 | 34.30 Mn |
| Dec 31, 2024 | -46.30 Mn |
| Dec 31, 2024 | -46.30 Mn |
| Sep 27, 2024 | 15.50 Mn |
| Sep 27, 2024 | 15.50 Mn |
| Jun 28, 2024 | 200,000.00 |
| Jun 28, 2024 | 200,000.00 |
| Mar 29, 2024 | -18.50 Mn |
| Mar 29, 2024 | -18.50 Mn |